<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03452020</url>
  </required_header>
  <id_info>
    <org_study_id>790-00038</org_study_id>
    <nct_id>NCT03452020</nct_id>
  </id_info>
  <brief_title>Evaluation of the Tyto Thermometer When Used in Clinical Care Setting</brief_title>
  <official_title>Evaluation of the Tyto Thermometer When Used in Clinical Care Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tyto Care Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tyto Care Ltd</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who present to the Emergency Department will be evaluated for eligibility to the
      study. Those meeting all the inclusion criteria and none of the exclusion criteria will
      undergo an informed consent process and will sign a written consent. Within each age group
      both afebrile and febrile patients will be represented.

      The patients will be divided into 3 study groups by age:

      Group 1: up to 1 year Group 2: 1 to 5 years Group 3: older than 5 years

      The following temperature measurements will be taken:

        1. Three temperature measurements using the Tyto thermometer

        2. Temperature measurement using the standard of care

        3. Three temperature measurements using the predicate device
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 24, 2018</start_date>
  <completion_date type="Anticipated">June 24, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 24, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body temperature measurement</measure>
    <time_frame>a period of no more than 12 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Body Temperature Measurement</condition>
  <arm_group>
    <arm_group_label>Tyto Thermometer, SoC Thermometer, Predicate IR Th</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All the study participants undergo temperature measurements with:
Tyto Thermometer
Standard of Care thermometer
Predicate IR thermometer</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Temperature measurementsusing the Tyto thermometer, the standard of care thermometer and the predicate thermometer</intervention_name>
    <description>Temperature measurements using the Tyto thermometer, the standard of care thermometer and the predicate thermometer</description>
    <arm_group_label>Tyto Thermometer, SoC Thermometer, Predicate IR Th</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female, of any age

          2. Subject or Parent/Guardian: able to communicate with study personnel;

          3. Subject or Parent/Guardian: able to understand the nature of the study and provide
             written informed consent

          4. Subject or Parent/Guardian willing to comply with study procedures

        Exclusion Criteria:

          1. Cognitive impairment, history of dementia, psychiatric disorders, mental disorders or
             PDD.

          2. Subject or legal guardian unwilling to sign informed consent form

          3. Those with signs or recent history of inflammation or infection of the forehead or at
             the Reference Clinical Test site (site of temperature measurement in any one of the
             devices used).

          4. Subjects currently using cooling blankets, ice on their forehead or fans.

          5. Subjects receiving treatment with antipyretics, barbiturates, antipsychotics for the
             past 3 hours.

          6. Subjects receiving current systemic treatment with thyroid preparations,
             corticosteroids or underwent immunizations during the past 7 days.

          7. Subjects with documented illicit drug use or alcoholic intoxication

          8. Those participating in a clinical trial of an investigational medicinal product

          9. Carriers of multi drug resistant bacteria

         10. Pregnancy

         11. CTAS score of 1-2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yehezkel Waisman, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Department of Emergency Medicine, Schneider Children's Medical Center of Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stella Raizelman Perry, MSc</last_name>
    <phone>972.72.221.0750</phone>
    <email>stellar@tytocare.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ofer Tzadik, Eng</last_name>
    <phone>972524761210</phone>
    <email>ofert@tytocare.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Schneider Children's Medical Center of Israel</name>
      <address>
        <city>Petah Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Assaf Sharabi, MD</last_name>
      <phone>972544747245</phone>
      <email>AssafSh@clalit.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2018</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

